InfasurfAero™ Versus Sham Treatment in Preterm Newborns with RDS

Last updated: March 25, 2025
Sponsor: ONY
Overall Status: Active - Recruiting

Phase

3

Condition

Lung Injury

Respiratory Failure

Treatment

Infasurf Aero™

Clinical Study ID

NCT05960929
AERO-05 Protocol
  • Ages 29-36
  • All Genders

Study Summary

The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Inclusion criteria include ALL of the following:

  1. Written informed consent obtained by parent or legal representative prior to orafter birth

  2. Gestational age at birth ≥ 29 0/7 AND ≤ 35 6/7 weeks

  3. Birthweight ≥ 1,000 AND ≤ 3,500 grams

  4. Age ≥ 1 hour AND ≤ 6 hours

  5. Clinical diagnosis of surfactant-deficient RDS, with EITHER i. a Silverman-AndersonRetraction Score ≥ 5 (in Room Air), OR ii. signs of respiratory distress (tachypnea,retractions, grunting) AND radiographic confirmation

  6. Require CPAP

  7. Respiratory Severity Score (RSS) ≥ 1.25 AND ≤ 2.4

  8. If subject is >346/7 weeks' gestation a chest radiograph is required

Exclusion

Exclusion Criteria:

Exclusion criteria are ANY of the following:

  1. Surfactant administration prior to randomization

  2. Mechanical ventilation prior to randomization

  3. Major congenital anomaly (suspected or confirmed)

  4. Abnormality of the airway (suspected or confirmed)

  5. Respiratory distress presumed secondary to an etiology other than RDS (e.g.,suspected pulmonary hypoplasia, pneumothorax, meconium aspiration syndrome,pneumonia, septic or hypovolemia shock, hypoxic ischemic encephalopathy)

  6. Apgar score < 3 at 5 minutes of age

  7. Umbilical cord gas pH <7.0 or BD > 10

  8. Any condition that, in the opinion of the Investigator, would place the neonate atundue risk

Study Design

Total Participants: 220
Treatment Group(s): 1
Primary Treatment: Infasurf Aero™
Phase: 3
Study Start date:
January 01, 2025
Estimated Completion Date:
April 01, 2026

Study Description

This single-dose, double-blind, random allocation, sham-control, clinical trial will recruit spontaneously breathing newborns with RDS stable on non-invasive nasal respiratory support. Enrolled clinical study subjects will be randomly allocated to receive respiratory air with Infasurf® (Intervention Arm) or respiratory air alone (Sham Control Arm) through the InfasurfAero™.

The objectives of this clinical study are to i) assess the effectiveness of a single dose of Infasurf administered through the InfasurfAero in preventing CPAP failure, and ii) assess the safety of Infasurf administered through the InfasurfAero.

Subjects will be enrolled at one of 10+ sites. 7 sites are currently recruited.

Connect with a study center

  • Phoenix Children's

    Phoenix, Arizona 85016
    United States

    Active - Recruiting

  • St. Josephs Hospital and Medical Center

    Phoenix, Arizona 85013
    United States

    Active - Recruiting

  • Sharp Mary Birch Hospital for Women & Newborns

    San Diego, California 92123
    United States

    Active - Recruiting

  • University of Florida -Jacksonville

    Jacksonville, Florida 32209
    United States

    Active - Recruiting

  • Johns Hopkins All Children's Hospital

    Saint Petersburg, Florida 33701
    United States

    Site Not Available

  • Kapi'olani Medical Center for Women & Children

    Honolulu, Hawaii 96826
    United States

    Active - Recruiting

  • Jersey Shore University Medical Center

    Neptune, New Jersey 07753
    United States

    Active - Recruiting

  • Sisters of Charity Hospital

    Buffalo, New York 14214
    United States

    Active - Recruiting

  • Jackson-Madison County General Hospital

    Jackson, Tennessee 38301
    United States

    Site Not Available

  • Western TN- Jackson-Madison County General Hospital

    Jackson, Tennessee 38301
    United States

    Active - Recruiting

  • Utah Valley Hospital

    Provo, Utah 84604
    United States

    Active - Recruiting

  • Unity Point Meriter

    Madison, Wisconsin 53715
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.